Skip to content

Gyre Therapeutics, Inc. GYRE All Other Segments — Operating Expenses

Other segment segments

Gyre Pharmaceuticals
$25.59M+39.7%
Gyre
$6.28M+330%

Similar metrics at other companies

Navient logo
NAVIAll Other Segments — Operating Expenses
$34M-35.8%
Investors Title Company logo
ITICAll Other — Operating Expenses
$3.13M+22.1%
Investors Title Company logo
ITICAll Other — Other Operating Expenses
$4.14M+42.2%
Alarm.com Holdings logo
ALRMOther — Operating Expenses
$22.09M+36.2%
Target Hospitality logo
THAll Other Segments — Other Cost Of Operating Revenue
$36K+9.1%
Navient logo
NAVIAll Other Segments — Other Expenses
$3M-40.0%

Other financials

Income statement

See full
Revenue$22.5M+2.1%
Gross profit$21.3M+0.6%
Operating income-$9.4M-512%
Net income-$8.7M-422%
EPS (diluted)-$0.10

Balance sheet

See full
Cash & equivalents$37.5M+149%
Total debt$823.0K-48.1%
Total equity$101.3M+48.7%
Total assets$162.0M+24.8%

Cash flow

See full
Operating cash flow$3.2M+2,565%
CapEx$178.0K+45.9%
Free cash flow$3.0M+1,296%

Valuation

See full
Market cap$694.58M-4.7%
Enterprise value$657.9M-8.0%
P/S5.9×-1.3×

Profitability

See full
Gross margin95.1%-1.1pp
Operating margin-0.1%-10.4pp
Net margin6.3%+3.3pp
FCF margin2.6%

Returns & leverage

See full
Return on equity8.2%+4.2pp
Debt / equity0.0×
Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s all other segments — operating expenses.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s all other segments — operating expenses?
Gyre Therapeutics, Inc. (GYRE) reported all other segments — operating expenses of $6K in Q1 2026.
How has Gyre Therapeutics, Inc.'s all other segments — operating expenses changed year-over-year?
Gyre Therapeutics, Inc.'s all other segments — operating expenses increased by 100.0% year-over-year, from $3K to $6K.
What is the long-term trend for Gyre Therapeutics, Inc.'s all other segments — operating expenses?
Over 2 years (2022 to 2025), Gyre Therapeutics, Inc.'s all other segments — operating expenses has grown at a -61.8% compound annual growth rate (CAGR), from $130K to $19K.
What does all other segments — operating expenses mean?
This metric aggregates all costs associated with the day-to-day operations of the 'All Other Segments' business unit, including selling, general, administrative, and research expenses. It serves as a comprehensive measure of the total operational burden required to run these specific business activities. Comparing this to segment revenue helps determine the operational leverage of the segment.